Leica Biosystems To Acquire Aperio

27-08-2012: Leica Biosystems announced that an affiliate has entered into a definitive agreement to acquireAperio, a leading provider of ePathology solutions.

Aperio will be integrated into Leica Biosystems. Together, the two businesses will leverage each other's strengths to grow and expand digital pathology into the global Life Science and Healthcare markets. The integrated business will provide industry leading solutions in each step of the anatomical pathology workflow, from sample preparation and staining, to imaging and reporting. The company will continue to offer both the Aperio and the existing Leica portfolio of Digital Pathology solutions, so that customers will enjoy more freedom to choose a solution that meets their individual needs.